Why have ovarian cancer mortality rates declined? Part III. Prospects for the future Review

Sopik, Victoria, Rosen, Barry, Giannakeas, Vasily et al. (2015). Why have ovarian cancer mortality rates declined? Part III. Prospects for the future . Gynecologic Oncology, 138(3), 757-761. 10.1016/j.ygyno.2015.06.019

cited authors

  • Sopik, Victoria; Rosen, Barry; Giannakeas, Vasily; Narod, Steven A

sustainable development goals

authors

publication date

  • September 1, 2015

published in

keywords

  • ADVANCED EPITHELIAL OVARIAN
  • ADVANCED-STAGE OVARIAN
  • CONFER SUSCEPTIBILITY
  • FALLOPIAN-TUBE
  • GERMLINE MUTATIONS
  • HIGH-RISK
  • Life Sciences & Biomedicine
  • Mortality
  • NEOADJUVANT CHEMOTHERAPY
  • Obstetrics & Gynecology
  • Oncology
  • Ovarian cancer
  • PRIMARY DEBULKING SURGERY
  • Prevention
  • SERUM CA-125
  • Science & Technology
  • Screening
  • TUMOR-MARKER
  • Treatment

Digital Object Identifier (DOI)

start page

  • 757

end page

  • 761

volume

  • 138

issue

  • 3